DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any shareholder dissent on the equity plan amendment, but expect smooth passage of all proposals given management's unanimous recommendation.
Final — all horizons settled through T+60d
CLYM ▲ +32.42% at T+60d
NEUTRAL call +32.42% · α vs SPY +27.64% · entry $9.50 → $12.58
T+1d
-2.53%
call -2.53% · α -2.04%
$9.26
settled 6mo ago
T+5d
+2.00%
call +2.00% · α +1.60%
$9.69
settled 6mo ago
T+20d
+19.89%
call +19.89% · α +14.94%
$11.39
settled 5mo ago
T+60d
+32.42%
call +32.42% · α +27.64%
$12.58
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Climb Bio, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting, proposing the election of two directors, ratification of auditors, and amendments to its charter and equity plan. This is a routine filing with no material changes or activist involvement.
Key Financial Metrics
Vote
director election
Meeting
2026-06-05
Key Facts
- Proposes election of two Class II directors: Alexander (Bo) Cumbo and Douglas Williams, Ph.D.
- Seeks ratification of PricewaterhouseCoopers LLP as independent auditor.
- Proposes amendment to remove directors for cause and to modify equity plan share pool calculation.
- Follows recent executive departure of CFO's principal accounting officer, but no board shake-up or activist pressure is indicated.
Financial Impact
No immediate financial impact; routine corporate governance matters.
governanceequity compensation
Risk Factors
- Potential shareholder concern over equity plan changes increasing dilution.
- Governance risk if director nominees face unexpected opposition.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177302 |
| Document: 0001193125-26-177302-index-headers.html | 0001193125-26-177302 |
| Document: 0001193125-26-177302-index.html | 0001193125-26-177302 |
| Document: 0001193125-26-177302.txt | 0001193125-26-177302 |
20 reports for CLYM
80% Hit rate @ T+1 Went positive at some point 4 of 5 best @ T+1▲ +6.79%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+1 | — | — |
Oct 23, 2026 2d ago | 8-K | $10.47 | awaiting T+1 | — | $9.07 (−13.37%) |
Oct 23, 2026 2d ago | Press Release | $10.34 | awaiting T+1 | — | $9.07 (−12.28%) |
Sep 22, 2026 4w ago | Institutional Cluster | $14.21 $12.52 | ▼ −11.89% | ▼ −11.17% | $9.07 (−36.17%) |
Sep 3, 2026 7w ago | 8-K | $14.59 $15.52 | ▲ +6.37% | ▲ +6.76% | $9.07 (−37.83%) |
Aug 14, 2026 10w ago | 8-K | $16.33 $17.44 | ▲ +6.80% | ▲ +7.27% | $9.07 (−44.46%) |
Aug 6, 2026 11w ago | 8-K | $14.00 $14.00 | · 0.00% | ▼ −0.61% | $9.07 (−35.21%) |
Jun 30, 2026 16w ago | 144 | $13.29 $12.90 | ▼ −2.93% | ▼ −2.80% | $9.07 (−31.75%) |
Jun 12, 2026 19w ago | 8-K | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $9.07 (+21.06%) |
Jun 12, 2026 19w ago | 424B5 | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $9.07 (+21.06%) |
Showing 10 of 20
US Market Status
Market Open — Closes in 1h 7m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers